CELGR Projected Dividend Yield
Contingent Value Rt 12/31/2030/Bristol Myers Squibb Co. ( NYSE : CELGR )Bristol-Myers Squibb Co. is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. 15 YEAR PERFORMANCE RESULTS |
CELGR Dividend History Detail CELGR Dividend News CELGR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
Feb 23, 2024 |
Mar 07, 2024 |
Mar 09, 2024 |
Mar 11, 2024 |
0.0199 |
2024 Total: |
0.0199 |
||||
2022 |
Feb 25, 2022 |
Mar 03, 2022 |
Mar 06, 2022 |
Mar 07, 2022 |
0.1046 |
2022 Total: |
0.1046 |
||||
2021 |
Feb 23, 2021 |
Mar 04, 2021 |
Mar 05, 2021 |
Mar 08, 2021 |
0.1425 |
2021 Total: |
0.1425 |
||||
2020 |
Mar 09, 2020 |
Mar 18, 2020 |
Mar 19, 2020 |
Mar 20, 2020 |
0.1479 |
2020 Total: |
0.1479 |